Inflammatory Marker Levels, Age, Race and Prior Treatment Burden Independently Predict Delayed Hematologic Recovery after BCMA-Directed CART Therapy in Multiple Myeloma

Inflammatory Marker Levels, Age, Race and Prior Treatment Burden Independently Predict Delayed Hematologic Recovery After BCMA-directed CART Therapy in Multiple Myeloma Introduction: With the advent of two approved anti-BCMA products and several additional investigational cellular therapies, the use...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2023-11, Vol.142 (Supplement 1), p.2002-2002
Hauptverfasser:	Thibaud, Santiago, Catlett, Jerrel, Bodnar, Saoirse, Mia, MD Babu, Chari, Ajai, Richter, Joshua, Cho, Hearn Jay, Sanchez, Larysa J, Rodriguez, Cesar, Rossi, Adriana C, Jagannath, Sundar, Richard, Shambavi, Parekh, Samir
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!